NEWS

01/05/2019 – ChemICare awarded funding from the European Union’s Horizon 2020 research and innovation programme (SME Instrument). 

PRESS REVIEW

PUBLICATIONS

• Cordero-Sanchez C*, Riva B*, Reano S*, Clemente N, Zaggia I, Ruffinatti FA, Potenzieri A,
  Pirali T, Raffa S, Sangaletti S, Colombo MP, Bertoni A, Garibaldi M, Filigheddu N*,
  Genazzani AA*. A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks
  of tubular aggregate myopathy. Disease Models & Mechanisms. 2019, 3; 13(2).

• Riva B*, Griglio A*, Serafini M, Cordero-Sanchez C, Aprile S, Di Paola S, Gugliandolo E,
  Alansary, D, Biocotino I, Lim D, Grosa G, Galli U, Niemeyer B, Sorba G, Canonico PL,
  Cuzzocrea S, Genazzani AA, Pirali T. Pyrtriazoles, a Novel Class of Store-Operated Calcium
  Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in
  Acute Pancreatitis. J. Med. Chem. 2018, 61, 9756−9783.

• Garibaldi M, Fattori F, Riva B, Labasse C, Brochier G, Ottaviani P, Sacconi S, Vizzaccaro E,
  Laschena F, Romero N, Genazzani A, Bertini E, Antonini G. A novel gain-of-function
  mutation in ORAI1 causes late-onset Tubular Aggregate Myopathy and congenital miosis.
  Clin Genet, 2017, 91, 780-786.

VIDEO